ARCHIVES

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

This article is from The Cancer Letter archive.

Vol. 33 No. 13 | April 6, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

January 16, 2009

NCI Extramural Programs: NCAB Approves Guidelines for Cancer Center Grants

March 7, 1997

Children With Recurrent Hodgkin’s Respond To Gemcitabine, Vinorelbine

March 27, 2009

RFA: Clinical Correlative Studies In Solid Tumors

April 3, 1992

NCI Records Clear Flood Of Intervention For Man Accused Of Illegal Payoffs

February 3, 1978

Draft of National Action Plan On Breast Cancer Targets Health Care, Research, Policy

March 23, 1994